Advanced search
Publication Cover
Blood Pressure Volume 31, 2022 - Issue 1
Submit an article Journal homepage
1,964
Views
0
CrossRef citations to date
0
Altmetric
Original Articles

Central and brachial pulse pressure predicts cardiovascular and renal events in treated hypertensive patients

Tsuneo Takenakaa Kokusai Iryo Fukushi Daigaku, Nephrology, Minato-ku, Tokyo, JapanCorrespondence[email protected]
,
Yoichi Ohnob Saitama Ika Daigaku, Nephrology, Iruma-gun, Saitama, Japan
,
Kazuo Eguchic Jichi Ika Daigaku Fuzoku Byoin, Cardiology, Shimotsuke, Tochigi, Japan
,
Hiroshi Miyashitac Jichi Ika Daigaku Fuzoku Byoin, Cardiology, Shimotsuke, Tochigi, Japan
,
Hiromichi Suzukib Saitama Ika Daigaku, Nephrology, Iruma-gun, Saitama, Japan
&
Kazuyuki Shimadac Jichi Ika Daigaku Fuzoku Byoin, Cardiology, Shimotsuke, Tochigi, Japan
Pages 64-70 | Received 05 Oct 2021, Accepted 31 Mar 2022, Published online: 19 Apr 2022

References

  • Eguchi K, Miyashita H, Takenaka T, et al. High central blood pressure is associated with incident cardiovascular events in treated hypertensives: the ABC-J II study. Hypertens Res. 2018;41(11):947–956.
  • Terentes-Printzios D, Gardikioti V, Vlachopoulos C. Central over peripheral blood pressure: an emerging issue in hypertension research. Heart Lung Circ. 2021;30(11):1667–1674.
  • Williams B, Lacy PS, Thom SM, et al. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the conduit artery function evaluation (CAFE) study. Circulation. 2006;113(9):1213–1225.
  • Roman MJ, Devereux RB, Kizer JR, et al. Central pressure more strongly relates to vascular disease and outcome than does brachial pressure: the strong heart study. Hypertension. 2007;50(1):197–203.
  • Mitchell GF, Hwang SJ, Larson MG, et al. Transfer function-derived central pressure and cardiovascular disease events: the Framingham Heart Study. J Hypertens. 2016;34(8):1528–1534.
  • London GM, Safar ME, Pannier B. Aortic aging in ESRD: structural, hemodynamic, and mortality implications. JASN. 2016;27(6):1837–1846.
  • Takenaka T, Suzuki H, Eguchi K, et al. Elevated pulse amplification in hypertensive patients with advanced kidney disease. Hypertens Res. 2018;41(4):299–307.
  • Yamashita S, Dohi Y, Takase H, et al. Central blood pressure reflects left ventricular load, while brachial blood pressure reflects arterial damage. Blood Press. 2014;23(6):356–362.
  • Miyashita H, Aizawa A, Hashimoto J, et al. Cross-sectional characterization of all classes of antihypertensives in terms of central blood pressure in Japanese Hypertensive Patients. Am J Hypertens. 2010;23(3):260–268.
  • O'Rourke MF, Vlachopoulos C, Graham RM. Spurious systolic hypertension in youth. Vasc Med. 2000;5(3):141–145.
  • Takazawa K, Kobayashi H, Shindo N, et al. Relationship between radial and central arterial pulse wave and evaluation of central aortic pressure using the radial arterial pulse wave. Hypertens Res. 2007;30(3):219–228.
  • Herbert A, Cruickshank JK, Laurent S, et al. Establishing reference values for central blood pressure and its amplification in a general healthy population and according to cardiovascular risk factors. Eur Heart J. 2014;35(44):3122–3133.
  • Millasseau SC, Patel SJ, Redwood SR, et al. Pressure wave reflection assessed from the peripheral pulse: is a transfer function necessary?. Hypertension. 2003;41(5):1016–1020.
  • Lin MM, Cheng HM, Sung SH, et al. Estimation of central aortic systolic pressure from the second systolic peak of the peripheral upper limb pulse depends on central aortic pressure waveform morphology. J Hypertens. 2012;30(3):581–586.
  • Kannel WB, Cobb J. Left ventricular hypertrophy and mortality-results from the Framingham Study. Cardiology. 1992;81(4–5):291–298.
  • Schoenfeld DA. Sample-size formula for the proportional-hazards regression model. Biometrics. 1983;39(2):499–503.
  • Suzuki H, Kanno Y. Efficacy of candesartan on outcome in Saitama trial (E-COST) group. Effects of candesartan on cardiovascular outcomes in Japanese Hypertensive Patients. Hypertens Res. 2005;28(4):307–314.
  • Umemura S, Arima H, Arima S, et al. The Japanese Society of Hypertension Guidelines for the management of Hypertension (JSH 2019). Hypertens Res. 2019;42(9):1235–1481.
  • Lee CM, Barzi F, Woodward M, et al. Adult height and the risks of cardiovascular disease and major causes of death in the Asia-Pacific region: 21,000 deaths in 510,000 men and women. Int J Epidemiol. 2009;38(4):1060–1071.
  • Judd E, Calhoun DA. Apparent and true resistant hypertension: definition, prevalence and outcomes. J Hum Hypertens. 2014;28(8):463–468.
  • Temmar M, Jankowski P, Peltier M, et al. Intraaortic pulse pressure amplification in subjects at high coronary risk. Hypertension. 2010;55(2):327–332.
  • Sarnak MJ, Levey AS, Schoolwerth AC, et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on kidney in cardiovascular disease, high blood pressure research, clinical cardiology, and epidemiology and prevention. Circulation. 2003;108(17):2154–2169.
  • Nakai S, Hanafusa N, Masakane I, et al. An overview of regular dialysis treatment in Japan (as of 31 December 2012). Ther Apher Dial. 2014;18(6):535–602.
  • Briet M, Boutouyrie P, Laurent S, et al. Arterial stiffness and pulse pressure in CKD and ESRD. Kidney Int. 2012;82(4):388–400.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.